MOORE JOHN R
Insider CIK 1191702 · ARRY VP, General Counsel · NVLS Director · EWTX General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 6,718 | — | $0 | 20,157 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 15,995 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,419 | $43.80 | $106.0K | 17,697 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 99 | $44.50 | $4.4K | 20,116 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 59 | $44.41 | $2.6K | 20,215 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 6,718 | — | $0 | 22,713 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,439 | $43.81 | $106.9K | 20,274 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 6,718 | — | $0 | 20,157 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,419 | $43.80 | $105.9K | 17,697 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 99 | $44.50 | $4.4K | 20,116 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 59 | $44.41 | $2.6K | 20,215 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,439 | $43.81 | $106.8K | 20,274 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 6,718 | — | $0 | 22,713 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 15,995 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 17,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 161,250 | — | $0 | 161,250 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 26,875 | — | $0 | 26,875 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 12,312 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-12 | 2025-08-14 | 2,098 | $13.39 | $28.1K | 10,214 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-05-02 | 2025-05-07 | 1,930 | $16.45 | $31.7K | 6,531 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 8,461 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-09-23 | 2024-09-24 | 20,922 | — | $0 | 41,636 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-23 | 2024-09-24 | 20,922 | $27.63 | $578.1K | 3,252 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-23 | 2024-09-24 | 20,922 | $0.71 | $14.9K | 24,174 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-09-20 | 2024-09-24 | 50,000 | — | $0 | 62,558 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-20 | 2024-09-24 | 50,000 | $0.71 | $35.5K | 53,252 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 50,000 | $28.37 | $1.42M | 3,252 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 138,750 | — | $0 | 138,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 23,125 | — | $0 | 23,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-05-02 | 2024-05-03 | 1,956 | $18.91 | $37.0K | 3,252 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 5,209 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 5,208 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-09 | 2024-02-09 | 8,029 | — | $0 | 93,162 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-09 | 2024-02-09 | 8,029 | $20.01 | $160.7K | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-09 | 2024-02-09 | 8,029 | $1.93 | $15.5K | 8,029 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-08 | 2024-02-09 | 3,813 | — | $0 | 101,191 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-08 | 2024-02-09 | 3,813 | $1.93 | $7.4K | 3,813 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-08 | 2024-02-09 | 3,813 | $20.01 | $76.3K | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-07 | 2024-02-09 | 17,993 | — | $0 | 105,004 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-07 | 2024-02-09 | 17,993 | $20.00 | $359.9K | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-07 | 2024-02-09 | 17,993 | $1.93 | $34.7K | 17,993 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-12-27 | 2023-12-28 | 8,497 | $10.50 | $89.2K | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-08-17 | 2023-08-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-05-02 | 2023-05-03 | 1,897 | $8.90 | $16.9K | 6,565 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 10,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 8,462 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-10-03 | 2022-10-05 | 4,730 | — | $0 | 122,997 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-10-03 | 2022-10-05 | 4,730 | $1.93 | $9.1K | 7,730 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-10-03 | 2022-10-05 | 4,730 | $9.76 | $46.2K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-09-06 | 2022-09-08 | 4,730 | — | $0 | 127,727 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-09-06 | 2022-09-08 | 2,351 | $10.99 | $25.8K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-09-06 | 2022-09-08 | 2,379 | $10.83 | $25.8K | 5,351 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-09-06 | 2022-09-08 | 4,730 | $1.93 | $9.1K | 7,730 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-08-08 | 2022-08-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-08-03 | 2022-08-05 | 4,502 | — | $0 | 112,558 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-08-03 | 2022-08-05 | 4,730 | — | $0 | 132,457 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-08-03 | 2022-08-05 | 4,730 | $1.93 | $9.1K | 7,730 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-08-03 | 2022-08-05 | 9,232 | $9.31 | $85.9K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-08-03 | 2022-08-05 | 4,502 | $0.71 | $3.2K | 12,232 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-07-06 | 2022-07-07 | 1,046 | — | $0 | 137,187 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-07-06 | 2022-07-07 | 1,046 | $1.93 | $2.0K | 4,046 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-07-06 | 2022-07-07 | 1,046 | $8.54 | $8.9K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-07-05 | 2022-07-07 | 3,684 | — | $0 | 138,233 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-07-05 | 2022-07-07 | 4,502 | — | $0 | 117,060 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-07-05 | 2022-07-07 | 3,684 | $1.93 | $7.1K | 6,684 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-07-05 | 2022-07-07 | 4,502 | $0.71 | $3.2K | 11,186 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-07-05 | 2022-07-07 | 8,186 | $8.35 | $68.4K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-21 | 2022-06-21 | 17,570 | — | $0 | 141,917 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-21 | 2022-06-21 | 13,508 | — | $0 | 121,562 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-21 | 2022-06-21 | 31,078 | $7.29 | $226.6K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-21 | 2022-06-21 | 13,508 | $0.71 | $9.6K | 16,508 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-21 | 2022-06-21 | 17,570 | $1.93 | $33.9K | 34,078 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-17 | 2022-06-21 | 22,127 | — | $0 | 159,487 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-17 | 2022-06-21 | 22,127 | $6.62 | $146.5K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-17 | 2022-06-21 | 22,127 | $1.93 | $42.7K | 25,127 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-16 | 2022-06-21 | 14,722 | — | $0 | 181,614 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-16 | 2022-06-21 | 14,722 | $1.93 | $28.4K | 17,722 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-16 | 2022-06-21 | 14,722 | $6.17 | $90.8K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-15 | 2022-06-15 | 18,075 | — | $0 | 135,070 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-15 | 2022-06-15 | 585 | — | $0 | 196,336 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-15 | 2022-06-15 | 585 | $6.11 | $3.6K | 21,075 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-15 | 2022-06-15 | 585 | $1.93 | $1.1K | 21,660 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-15 | 2022-06-15 | 18,075 | $0.71 | $12.8K | 21,075 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-15 | 2022-06-15 | 18,075 | $6.11 | $110.4K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-14 | 2022-06-15 | 3,628 | — | $0 | 153,145 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-14 | 2022-06-15 | 3,628 | $6.02 | $21.8K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-14 | 2022-06-15 | 3,628 | $0.71 | $2.6K | 6,628 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-13 | 2022-06-15 | 4,093 | — | $0 | 156,773 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-13 | 2022-06-15 | 4,093 | $6.01 | $24.6K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-13 | 2022-06-15 | 4,093 | $0.71 | $2.9K | 7,093 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-10 | 2022-06-10 | 7,125 | — | $0 | 160,866 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-10 | 2022-06-10 | 7,125 | $0.71 | $5.1K | 10,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-10 | 2022-06-10 | 7,125 | $6.05 | $43.1K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-09 | 2022-06-10 | 7,615 | — | $0 | 167,991 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-09 | 2022-06-10 | 7,615 | $0.71 | $5.4K | 10,615 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-09 | 2022-06-10 | 7,615 | $6.49 | $49.4K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-08 | 2022-06-10 | 12,566 | — | $0 | 175,606 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-08 | 2022-06-10 | 12,566 | $6.63 | $83.3K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-08 | 2022-06-10 | 12,566 | $0.71 | $8.9K | 15,566 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-07 | 2022-06-07 | 17,150 | — | $0 | 188,172 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-07 | 2022-06-07 | 973 | — | $0 | 196,921 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-07 | 2022-06-07 | 973 | $1.93 | $1.9K | 3,973 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-07 | 2022-06-07 | 973 | $6.61 | $6.4K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-07 | 2022-06-07 | 17,150 | $0.71 | $12.2K | 20,150 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-07 | 2022-06-07 | 17,150 | $6.61 | $113.4K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-06 | 2022-06-07 | 13,934 | — | $0 | 197,894 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-06 | 2022-06-07 | 13,934 | $1.93 | $26.9K | 16,934 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-06 | 2022-06-07 | 13,934 | $6.03 | $84.0K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-06-03 | 2022-06-07 | 15,230 | — | $0 | 211,828 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-06-03 | 2022-06-07 | 15,230 | $6.05 | $92.1K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-06-03 | 2022-06-07 | 15,230 | $1.93 | $29.4K | 18,230 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2022-05-16 | 2022-05-18 | 10,800 | $7.42 | $80.1K | 3,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-05-01 | 2022-05-03 | 15,625 | — | $0 | 15,625 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-01-21 | 2022-01-25 | 5,400 | — | $0 | 205,322 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-01-21 | 2022-01-25 | 5,400 | $0.71 | $3.8K | 12,362 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2021-12-28 | 2021-12-30 | 5,400 | — | $0 | 210,722 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2021-12-28 | 2021-12-30 | 5,400 | $0.71 | $3.8K | 6,962 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-08-17 | 2021-08-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-04-01 | 2017-04-04 | 6,718 | — | $0 | 20,157 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-04 | 4,408 | $8.94 | $39.4K | 42,064 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-04-01 | 2017-04-04 | 6,718 | — | $0 | 46,472 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-06 | 6,370 | $8.94 | $56.9K | 40,102 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 131,250 | — | $0 | 131,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 21,875 | — | $0 | 21,875 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2016-09-12 | 2016-09-14 | 12,300 | — | $0 | 12,300 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 161,250 | — | $0 | 161,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 26,875 | — | $0 | 26,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-04-01 | 2016-04-05 | 2,505 | $3.00 | $7.5K | 39,754 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2015-09-11 | 2015-09-15 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-04-01 | 2015-04-03 | 161,250 | — | $0 | 161,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2015-04-01 | 2015-04-03 | 26,875 | — | $0 | 42,259 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-04 | 22,906 | — | $0 | 22,906 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-03-01 | 2015-03-04 | 7,542 | $7.96 | $60.0K | 15,364 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-03-01 | 2015-03-04 | 22,906 | $7.96 | $182.3K | 22,906 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-08-18 | 2014-08-20 | 45,812 | — | $0 | 45,812 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-04-01 | 2014-04-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-11-29 | 2013-12-03 | 11,666 | $5.79 | $67.5K | 20 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-11-13 | 2013-11-15 | 200 | $5.79 | $1.2K | 11,686 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-08-02 | 2013-08-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-08-02 | 2013-08-02 | 13,884 | — | $0 | 9,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-08-02 | 2013-08-02 | 43,884 | $7.03 | $308.5K | 11,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-08-02 | 2013-08-02 | 30,000 | $3.06 | $91.8K | 55,770 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-08-02 | 2013-08-02 | 13,884 | $3.01 | $41.8K | 25,770 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-08-01 | 2013-08-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-08-01 | 2013-08-02 | 14,241 | — | $0 | 23,259 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-08-01 | 2013-08-02 | 14,241 | $3.01 | $42.9K | 43,386 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-08-01 | 2013-08-02 | 12,500 | $2.74 | $34.3K | 29,145 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-08-01 | 2013-08-02 | 31,500 | $7.00 | $220.5K | 11,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-07-25 | 2013-07-25 | 4,759 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-07-25 | 2013-07-25 | 4,759 | $3.75 | $17.8K | 16,645 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-07-23 | 2013-07-25 | 5,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-07-23 | 2013-07-25 | 5,000 | $2.74 | $13.7K | 16,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-07-23 | 2013-07-25 | 5,000 | $6.50 | $32.5K | 11,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2013-04-23 | 2013-04-24 | 20,000 | — | $0 | 30,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2013-04-23 | 2013-04-24 | 20,000 | $6.52 | $130.4K | 11,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2013-04-23 | 2013-04-24 | 20,000 | $2.74 | $54.8K | 31,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2013-03-28 | 2013-04-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2012-10-08 | 2012-10-09 | 26,190 | $5.69 | $149.0K | 11,886 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2012-10-08 | 2012-10-09 | 2,357 | $5.69 | $13.4K | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2012-10-04 | 2012-10-05 | 11,886 | — | $0 | 38,076 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2012-03-30 | 2012-04-03 | 75,000 | — | $0 | 75,000 | SEC↗ |